Last reviewed · How we verify
Gardnerella Vaginalis Bacterial Vaginosis
Approved treatments
- Klaron · Merck & Co.
- Sulfabenzid · Johnson & Johnson
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Gardnerella Vaginalis Bacterial Vaginosis patent landscape — cliff calendar, originator estates, attackable patents
- Gardnerella Vaginalis Bacterial Vaginosis treatment landscape brief
- Gardnerella Vaginalis Bacterial Vaginosis treatment updates RSS
Frequently asked questions about Gardnerella Vaginalis Bacterial Vaginosis
What drugs treat Gardnerella Vaginalis Bacterial Vaginosis?
Tracked treatments include Klaron, Sulfabenzid.
What is the treatment for Gardnerella Vaginalis Bacterial Vaginosis?
Standard treatment for Gardnerella Vaginalis Bacterial Vaginosis includes Klaron, Sulfabenzid. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Gardnerella Vaginalis Bacterial Vaginosis patent cliff · Gardnerella Vaginalis Bacterial Vaginosis CI report
- Treatment: Klaron · Merck & Co.
- Treatment: Sulfabenzid · Johnson & Johnson
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing